ENTITY
Exelixis Inc

Exelixis Inc (EXEL US)

23
Analysis
Health CareUnited States
Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.
more
Company Presentation05 Nov 2025 06:00
Company Presentation29 Jul 2025 05:00
Company Presentation14 May 2025 05:00
Company Presentation07 May 2021 05:00
Company Presentation06 Aug 2021 05:00
x